@ShahidNShah
Artificial intelligence (AI) will cause enormous societal changes, including in biomedicine. Healthcare conditions in the United States make it ripe for AI disruption. We have a profit-driven, fragmented system with insufficient clinicians and clinical support; this system delivers expensive, disparate, error-ridden, and inefficient care.
AI in genomic medicine could significantly reshape U.S. healthcare by improving rare disease detection, genetic analysis, and clinical decision-making at a much faster scale than traditional methods. The article also raises concerns about how healthcare systems, clinicians, and regulators must adapt to maintain patient trust, oversight, and ethical use of AI-driven genomic tools.
Continue reading at nature.com
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2026 Netspective Foundation, Inc. All Rights Reserved.
Built on May 21, 2026 at 5:06am